Prothena Corp Public (PRTA) Liabilities and Shareholders Equity (2012 - 2026)

Prothena Corp Public (PRTA) posted quarterly Liabilities and Shareholders Equity of $349.9 million for Q1 2026, down 29.36% year-over-year from $495.3 million in Q1 2025, and up 7.07% quarter-over-quarter from $326.8 million in Q4 2025.

Prothena Corp Public (PRTA) Liabilities and Shareholders Equity (2012 - 2026) Analysis & Trends

Prothena Corp Public's Liabilities and Shareholders Equity history runs 15 years deep, the most recent figure standing at $349.9 million for Q1 2026.

  • In Q1 2026, Liabilities and Shareholders Equity fell 29.36% year-over-year to $349.9 million; the TTM figure through Mar 2026 stood at $1.4 billion (down 37.44% YoY), while the FY2025 annual figure was $326.8 million, down 40.27% from the prior year.
  • Liabilities and Shareholders Equity for Q1 2026 stood at $349.9 million, up from $326.8 million in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $758.0 million in Q4 2022, with the low at $326.8 million in Q4 2025.
  • The 5-year median for Liabilities and Shareholders Equity is $581.4 million (2022), against an average of $569.6 million.
  • The sharpest annual moves came in 2022 and 2025: Liabilities and Shareholders Equity jumped 53.12% in 2022, then slumped 40.76% in 2025.
  • Prothena Corp Public's Liabilities and Shareholders Equity stood at $758.0 million in 2022, then decreased by 8.13% to $696.4 million in 2023, then decreased by 21.44% to $547.1 million in 2024, then plunged by 40.27% to $326.8 million in 2025, then gained by 7.07% to $349.9 million in 2026.
  • Business Quant data shows PRTA's Liabilities and Shareholders Equity at $349.9 million in Q1 2026, $326.8 million in Q4 2025, and $352.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 27.42 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 41.73 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 10.03 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 4.32 Bn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 9.18 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 15.59 Mn
7 Royalty Pharma 33.72 Bn 35.84 Bn - 19.82 Bn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 5.56 Bn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 2.10 Bn
10 Prothena Corp Public 458.45 Mn 170.25 Mn - 302.58 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 302.58 Mn
Mar 31, 2026 349.89 Mn
Dec 31, 2025 326.80 Mn
Sep 30, 2025 352.63 Mn
Jun 30, 2025 399.07 Mn
Mar 31, 2025 495.34 Mn
Dec 31, 2024 547.11 Mn
Sep 30, 2024 595.25 Mn
Jun 30, 2024 645.57 Mn
Mar 31, 2024 623.19 Mn
Dec 31, 2023 696.38 Mn
Sep 30, 2023 746.92 Mn
Jun 30, 2023 720.65 Mn
Mar 31, 2023 741.59 Mn
Dec 31, 2022 758.04 Mn
Sep 30, 2022 554.44 Mn
Jun 30, 2022 549.59 Mn
Mar 31, 2022 581.41 Mn
Dec 31, 2021 609.37 Mn
Sep 30, 2021 632.70 Mn